NCT03467971View on ClinicalTrials.gov

A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

April 22, 2018

Study Completion Date

April 22, 2018

Conditions
Healthy
Interventions
DRUG

Metformin/Gliclazide Fixed Combination

Participants will receive single oral dose of Metformin 1000 mg and Gliclazide 30 mg fixed combination tablet in fasting or fed state.

Trial Locations (1)

Unknown

CECYPE, Mexico City

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT03467971 - A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants | Biotech Hunter | Biotech Hunter